Bad Debt Risk for Affiliated Medical Corporations
First written in FY2025. 1 of 2 entries say "Worsened", first in FY2026-H1. Latest entry: FY2026-H1.
Eucalia moved to the "Worse" side of this theme in 2026, 1 year after the typical company in this theme (2025).
3 other companies' latest entry also says "Worsened".
- FY2026-H1WorsenedAnnual report
「This was mainly because notes and accounts receivable decreased by ¥1,325,028 thousand, while cash and deposits increased by ¥1,887,836 thousand, operating loans included in other current assets increased by ¥865,636 thousand, and deposits increased by ¥782,368 thousand.」
Operating loans included in other current assets increased by ¥865,636 thousand, expanding loan exposure including to affiliated medical corporations. No bad debts were reported. - FY2025First statedAnnual report
「If the real estate market deteriorates and land prices fall sharply, the value of collateral real estate could decline, resulting in loan receivables with insufficient collateral. If an affiliated medical corporation's repayment capacity declines and repayment becomes difficult, bad debts could arise and affect the Group's operating results or financial condition.」
The risk of bad debts on working-capital loans to affiliated medical corporations due to falling collateral values or weaker repayment capacity was newly disclosed as a separate key risk.